Evidence map›Paper›PMID 31010886›Full record

ArticleRNA (New York, N.Y.)2019

eIF4G2 balances its own mRNA translation via a PCBP2-based feedback loop.

Victoria V Smirnova, Ekaterina D Shestakova, Dmitry V Bikmetov, Anastasia A Chugunova, Ilya A Osterman, Marina V Serebryakova, Olga V Sergeeva, Timofey S Zatsepin, Ivan N Shatsky, Ilya M Terenin

Open access · bronzeAbstract read
In one paragraph

Article in RNA (New York, N.Y.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. The T1D-associated lncRNAProceedings of the National Academy of Sciences of the United States of America · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Victoria V SmirnovaFaculty of Bioengineering and Bioinformatics, Lomonosov Moscow State University, Leninskie Gory, 119234 Moscow, Russia.ORCID 0000-0002-1472-3555
Ekaterina D ShestakovaDepartment of Biochemistry, School of Biology, Lomonosov Moscow State University, Leninskie Gory, Moscow, 119234, Russian Federation.ORCID 0000-0002-1562-0179
Dmitry V BikmetovFaculty of Bioengineering and Bioinformatics, Lomonosov Moscow State University, Leninskie Gory, 119234 Moscow, Russia.ORCID 0000-0001-6788-9156
Anastasia A ChugunovaChemistry Department, Lomonosov Moscow State University, Leninskie Gory, Moscow 119991, Russia.
Ilya A OstermanBelozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Leninskie Gory, Moscow 119992, Russia.
Marina V SerebryakovaBelozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Leninskie Gory, Moscow 119992, Russia.ORCID 0000-0002-5402-8215
Olga V SergeevaSkolkovo Institute of Science and Technology, Skolkovo, Moscow Region 143026, Russia.
Timofey S ZatsepinSkolkovo Institute of Science and Technology, Skolkovo, Moscow Region 143026, Russia.ORCID 0000-0003-0030-9174
Ivan N ShatskyBelozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Leninskie Gory, Moscow 119992, Russia.
Ilya M TereninBelozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Leninskie Gory, Moscow 119992, Russia.ORCID 0000-0002-4459-0781
Lomonosov Moscow State University · RUSkolkovo Institute of Science and Technology · RUSechenov University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Poly(rC)-binding protein 2 (PCBP2, hnRNP E2) is one of the most abundant RNA-binding proteins in mammalian cells. In humans, it exists in seven isoforms, which are assumed to play similar roles in cells. The protein is shown to bind 3'-untranslated regions (3'-UTRs) of many mRNAs and regulate their translation and/or stability, but nothing is known about the functional consequences of PCBP2 binding to 5'-UTRs. Here we show that the PCBP2 isoform f interacts with the 5'-UTRs of mRNAs encoding eIF4G2 (a translation initiation factor with a yet unknown mechanism of action, also known as DAP5) and Cyclin I, and inhibits their translation in vitro and in cultured cells, while the PCBP2 isoform e only affects Cyclin I translation. Furthermore, eIF4G2 participates in a cap-dependent translation of the PCBP2 mRNA. Thus, PCBP2 and eIF4G2 seem to regulate one another's expression via a novel type of feedback loop formed by the translation initiation factor and the RNA-binding protein.

Indexed as

Protein Biosynthesis5' Untranslated RegionsCells, CulturedEukaryotic Initiation Factor-4GHumansRNA-Binding ProteinsRNA, Messenger5' Untranslated RegionsEIF4G2 protein, humanEukaryotic Initiation Factor-4GPCBP2 protein, humanRNA-Binding ProteinsRNA, Messengerribosomal scanningtranslational controlαCP2

Identifiers

PMID31010886
PMCPMC6573783
OpenAlexW2942188614

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.